about
Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National GuidelineBlood-borne hepatitis in opiate users in iran: a poor outlook and urgent need to change nationwide screening policyPrevalence of HIV/AIDS among Iranian Prisoners: A Review ArticleImpact of neuraminidase inhibitors on influenza A(H1N1)pdm09-related pneumonia: an individual participant data meta-analysis.Pandemic 2009 influenza A (H1N1) infection among 2009 Hajj Pilgrims from Southern Iran: a real-time RT-PCR-based study.Titering of 2009 pandemic H1N1 influenza virus hemagglutinin inhibition antibody in nonvaccinated pregnant women in Shiraz, Southern Iran.Acceptance and rejection of influenza vaccination by pregnant women in southern Iran: physicians' role and barriers.The impact of environmental factors on traffic accidents in Iran.A Study on Hospitalized Patients' Payment in South of Iran after the First Round of Health Sector Reform.Establishment of a Population-based Registry of Inflammatory Bowel Diseases in Fars Province, IranFrom good to great physician: a critical ethnography based on patients' viewsMedical paraclinical standards, political economy of clinic, and patients' clinical dependency; a critical conversation analysis of clinical counseling in South of iran.Seroprevalence of anti-rubella and anti-measles IgG antibodies in pregnant women in Shiraz, Southern Iran: outcomes of a nationwide measles-rubella mass vaccination campaign.The association of health-promoting lifestyle with quality of life among the Iranian elderly.A randomized pilot trial on the effect of granulocyte-colony stimulating factor on antibody response in hemodialysis patients who had not responded to routine hepatitis B virus vaccine.High prevalence of Helicobacter pylori infection in Behcet's diseaseSymptom association probability and symptom sensitivity index: preferable but still suboptimal predictors of response to high dose omeprazoleFourteen Years of Experience of Liver Transplantation for Wilson's Disease; a Report on 107 Cases from Shiraz, IranHepatitis B and C virus-induced hepatitis: Apoptosis, autophagy, and unfolded protein responsePredictive Potential of Heart Rate Complexity Measurement: An Indication for Laparotomy Following Solid Organ InjurySatisfaction and Dissatisfaction Toward Urban Family Physician Program: A Population Based Study in Shiraz, Southern Iran.Hepatitis B and C in dialysis units in Iran: changing the epidemiology.Hospital mortality associated with stroke in southern iran.Denture Stomatitis and Candida Albicans in Iranian Population: A Systematic Review and Meta-AnalysisReligion as an empowerment context in the narrative of women with breast cancer.Use of C-Reactive Protein as a Diagnostic Tool for Early Detection of Bacterial Infection After Liver Transplantation.High rate of A2142G point mutation associated with clarithromycin resistance among Iranian Helicobacter pylori clinical isolates.New use of an old drug: chloroquine reduces viral and ALT levels in HCV non-responders (a randomized, triple-blind, placebo-controlled pilot trial).Prevalence of HIV, HCV, and High-Risk Behaviors for Substance Users in Drop in Centers in Southern Iran.Alterations in Th17 and the Respective Cytokine Levels in Helicobacter pylori-Induced Stomach Diseases.Determinants of poor outcome in patients with hepatitis A infection: a four-year retrospective study in Shiraz, Southern Iran.Cost-effectiveness analysis of adding low dose ribavirin to peginterferon alfa-2a for treatment of chronic hepatitis C infected thalassemia major patients in iran.Does delayed gastric emptying shorten the H pylori eradication period? A double blind clinical trial.Post-transplantation lymphoproliferative disorder after liver transplantation: report of 5 cases among more than 550 liver transplants in Iran.Maternal mortality rate in Fars Province: trends and associated factors in a community-based survey.The second international conference on reducing burden of traffic accidents, Shiraz, Iran.Comparison of metoclopramide oral tablets and solution in treatment of dysmotility-like dyspepsia.Efficacy and safety of jollab to treat functional dyspepsia: a randomized placebo-controlled clinical trial.Biliary tract complications after liver transplantation in a single center.Results of liver transplantation: analysis of 140 cases at a single center.
P50
Q28076883-0307D22C-2D78-4002-B6B5-077858B89130Q28535593-BE091756-551E-4852-B59A-E1E182201F9FQ29994497-112CC39B-D2E4-4F30-A22A-9B75DC7DB155Q30381799-5F5F2659-AF2D-4FDD-B11B-E877A7077CACQ30416736-FF775380-A0FC-4602-9110-40633BC59702Q30417281-BDB31C4F-B1C9-4109-9283-2A0BBF21CC32Q30421890-2F2BC235-79B7-4EEF-B879-DE202A8F72CBQ33562699-65BAD336-6311-4981-9579-221705121919Q33596101-D44C4558-9B90-4DB1-98C9-C3F5E8165536Q33597351-30BA9ACC-AC05-4A49-96A4-44D66A86D790Q33691248-1085C214-30B1-4708-8314-49B60B57039AQ34360408-8AAAB344-A4EC-47B0-84EA-C8990F5C6084Q34575995-C22917E1-DC14-4A85-B44E-79E03325ABFAQ34733659-ED5C8DB3-5569-4DA2-A483-B454CB2AF32AQ35047374-07B3A6EE-DCBB-4997-85F3-EE44C33B7250Q35135666-F0D077A1-39BA-4329-A14F-D4912F7B1EBAQ35598218-582A5F8E-B544-4DD7-98D5-3F41B050DF86Q36216217-86B5796B-1E60-494C-AE2C-B9155AC9C83DQ36373611-8E4C7DC4-3DEB-49C3-9A77-39F0D5B6210FQ36503966-D99B5D34-8096-4716-B13D-96B2AA1C9DD0Q36584754-6CF934EF-D281-4B87-B967-8406A1AAD679Q37220215-8062B93F-3365-4E62-B276-4932B1B55AADQ37338863-4CC54FF4-FA28-4F08-9028-0696749B7271Q37406013-429841DB-97FB-4C39-AE52-28D3F3F45FD8Q38427083-29E5E0DC-ABDE-47B6-8955-6E4E659A2A7BQ40459074-8B50EE89-592E-40AD-9395-A3189130E572Q40631623-9C262C11-F8C2-40FF-8915-E8D6B270DA4FQ40747582-DC04FD50-6644-4EBF-9D48-119937E62DC0Q41274804-030F89CC-B8AB-4979-9D40-20C8DCD941A8Q41290370-61EFACE2-82B4-40E5-B03B-9C912E91F5A7Q42235983-A3A2AF9F-8725-4413-8B51-FD2FA4167133Q42252742-DE1A129D-31E4-4117-AD25-C039CDE34E24Q42267363-9DD1B8FB-0A50-42F4-B54F-DCEDC501596AQ42922297-ECEAF50F-E8AA-4FB5-9DC8-1067AC8511C0Q43172267-81FF1616-CCB7-4D9D-81A5-F87AAC5183AFQ43233603-EBEA0B4B-B62D-4CD2-AC55-0367BFDEE846Q46578662-1921A2F6-D400-476C-8DEE-8D5C3BF979DFQ47429241-C9682E0E-4A4A-4BE8-9B60-563D30670A15Q47713641-B2866B66-8F2E-46D9-B119-9AA8B1177538Q47713654-4D76973E-E305-42F6-A6B0-CFBA1877326D
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kamran B Lankarani
@es
Kamran B. Lankarani
@en
Kamran B. Lankarani
@nl
Kamran B. Lankarani
@sl
type
label
Kamran B Lankarani
@es
Kamran B. Lankarani
@en
Kamran B. Lankarani
@nl
Kamran B. Lankarani
@sl
altLabel
KB Lankarani
@en
Kamran Lankarani
@en
Kamran bagheri Lankarani
@en
prefLabel
Kamran B Lankarani
@es
Kamran B. Lankarani
@en
Kamran B. Lankarani
@nl
Kamran B. Lankarani
@sl
P1053
P-2066-2017
P106
P1153
26647605100
56639033800
P21
P31
P3829
P496
0000-0002-7524-9017
P569
2000-01-01T00:00:00Z